Healthcare PharmAsia Market Study May 2000

 

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
30-May-2000
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
8143-01-00-00-00
SKU
HC00420-AP-MR_03633
Yes
SHARE

PharmAsia Market Study May 2000
Published on: 30-May-2000 | SKU: HC00420-AP-MR_03633

Need more details?

$1,000.00

$750.00 save 25 %

DownloadLink
Need more details?

Overview and Scope

  • Overview and Scope

Market Engineering Analysis ofthe Japanese Bronchitis and AllergicCoryza Products Market (1996-2006)

  • Market Definitions
  • Market Engineering Research Measurement System
  • Challenges Facing the Bronchitis and Allergic Coryza Markets in Japan
  • Market Engineering Valuation and Revenue Forecasts (1996-2006)

Marketing Engineering Research Analysis

  • Marketing Engineering Research Analysis
  • Market Forecasts
  • Demand Analysis
  • Competitive Structure

Market Engineering Strategic Recommendations for Bronchitis and Allergic Coryza Market

  • Market Engineering Strategic Recommendations for Bronchitis and Allergic Coryza Market
  • Shift the Focus of Product Development from Broad-Based Antibiotics and Antibacterials to Specialized and Effective Drugs for Bronchitis
  • Penetrate the BronchodilatorsSegment by Targeting Patients with Mild Bronchitis
  • Develop and Introduce Antibiotics with Different Chemical Functions; Preventive Drugs and Potentiating Agents for the Action of Other Antibiotics/Antibacterials
  • Penetrate the Influenza Vaccines and Anti-virus Drugs Segments
  • Trigger Early Diagnosis of Chronic Bronchitis Patients by Encouraging the Government to Regulate Active Information Activities to Create Awareness
  • Activate Co-marketing with Other Pharmaceutical Companies to Share Costs for R&D and Sales
  • Produce Generics for the Introduction of the Prospective Payment System
  • Develop Products for Allergic Coryza in OTC Segments and Co-sell the Products with Other Pharmaceutical Companies That Have Strong Distribution Channels
  • Develop Improved Anti-allergics to Compete with the Emerging Non-drug Therapies
  • Develop Complementary Products for Non-drug Therapies Like Laser Surgery and Anti-anaphylaxis Therapy
  • Innovate Current Anti-allergics and Reduce Impairment of Performance

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number 8143-01-00-00-00
Is Prebook No

PharmAsia Market Study May 2000

$1,000.00

Special Price $750.00 save 25 %

In stock
SKU
HC00420-AP-MR_03633